Ramesh Gupta, MD
Rheumatology · Memphis, TNNPI 1730143926
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $78,377 of the $81,201 with a category attached, or 96.5%. Astrazeneca UK Limited accounts for 96.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $58,408 and has fallen 99.9% since, to $79 in 2025. Among rheumatology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $738.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$78K
- AstraZeneca$408
- Novartis$383
- AbbVie$343
- Amgen$301
- Pfizer$293
- plus $1K from 18 others
Across 1,310 payments — averaging $4339.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1M
- Novartis$898K
- Janssen Research & Development, LLC$666K
- Astrazeneca UK Limited$616K
- Amgen$609K
- Gilead$350K
- plus $1.5M from 23 others
What the payments were for
- Consulting fees$78,37797%
- Grants$2400%
- Travel & lodging$800%
- Food & beverage$2,5053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 16 | $78,377 |
| AstraZeneca(2 entities) | 14 | $408 |
| Novartis | 4 | $383 |
| AbbVie | 3 | $343 |
| Amgen(2 entities) | 5 | $301 |
| Pfizer | 24 | $293 |
| E.r. Squibb & Sons, L.L.C. | 2 | $208 |
| GSK | 9 | $141 |
| IBSA Pharma Inc. | 1 | $125 |
| UCB, Inc. | 9 | $118 |
| Ultragenyx Pharmaceutical Inc. | 5 | $107 |
| Sobi, Inc | 3 | $55 |
| Novo Nordisk | 1 | $50 |
| Sanofi | 2 | $49 |
| Boehringer Ingelheim | 2 | $44 |
| Angiodynamics, Inc. | 1 | $38 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Bristol Myers Squibb | 1 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Mylan Institutional Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,201 in reported general payments places this provider in the 90th percentile of 127 rheumatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 243 | $9,903 |
| Leflunomide | 181 | $8,779 |
| MethotrexateMethotrexate Sodium | 182 | $4,594 |
| Prednisone | 376 | $3,045 |
| Diclofenac Sodium | 140 | $2,922 |
| Diflunisal | 17 | $2,170 |
| Flurbiprofen | 26 | $1,919 |
| Azathioprine | 54 | $1,593 |
| Methylprednisolone | 38 | $1,551 |
| Gabapentin | 53 | $1,338 |
| Colchicine | 18 | $916 |
| Sulfasalazine | 16 | $637 |
| Zolpidem Tartrate | 62 | $543 |
| Sulindac | 27 | $543 |
| Celecoxib | 25 | $531 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Memphis
- Raza HashmiMemphis$17K
- Alisha GuptaMemphis$9K
- Vaishnavi PulusaniMemphis$9K
- Titilola AkhigbeMemphis$6K
- Sudha GanguliMemphis$6K
- Joseph HuffstutterHixson$742K
- Brett SmithKnoxville$587K
- Satish OdhavJackson$527K
- Jacob AelionJackson$459K
- Marcus OwenMurfreesboro$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.